Related references
Note: Only part of the references are listed.A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug Interactions
Xia Li et al.
CLINICAL PHARMACOKINETICS (2020)
Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies
Lukas Kovar et al.
CLINICAL PHARMACOKINETICS (2020)
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
Lukas Kovar et al.
PHARMACEUTICS (2020)
Ontogeny Related Changes in the Pediatric Liver Metabolome
Christopher M. Wilson et al.
FRONTIERS IN PEDIATRICS (2020)
Data Digitizing: Accurate and Precise Data Extraction for Quantitative Systems Pharmacology and Physiologically-Based Pharmacokinetic Modeling
Jan-Georg Wojtyniak et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development
Venkata Yellepeddi et al.
CLINICAL PHARMACOKINETICS (2019)
Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients
Nina Hanke et al.
PHARMACEUTICS (2019)
Predictive Pediatric Modeling and Simulation Using Ontogeny Information
Ibrahim Ince et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Pediatric Dose Selection and Utility of PBPK in Determining Dose
Ian E. Templeton et al.
AAPS JOURNAL (2018)
P-Glycoprotein on Blood-Brain Barrier Plays a Vital Role in Fentanyl Brain Exposure and Respiratory Toxicity in Rats
Chenchen Yu et al.
TOXICOLOGICAL SCIENCES (2018)
Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review
Victoria C. Ziesenitz et al.
CLINICAL PHARMACOKINETICS (2018)
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients
Evelien J. M. Kuip et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
PBPK in Preterm and Term Neonates: A Review
Robin Michelet et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification
Daniel Moj et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Development of Physiologically Based Organ Models to Evaluate the Pharmacokinetics of Drugs in the Testes and the Thyroid Gland
S. Pilari et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics
B. Prasad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver
Margaret M. S. Thomson et al.
DRUG METABOLISM AND DISPOSITION (2016)
Pharmacokinetic Interaction of Intravenous Fentanyl With Ketoconazole
Victoria C. Ziesenitz et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Clinical Pharmacology of Fentanyl in Preterm Infants. A Review
Gian Maria Pacifici
PEDIATRICS AND NEONATOLOGY (2015)
Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein
Sudeep Raj Bista et al.
XENOBIOTICA (2015)
Ethics of Drug Studies in the Newborn
Robert M. Ward et al.
PEDIATRIC DRUGS (2015)
Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
A. R. Maharaj et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam
A. R. Maharaj et al.
AAPS JOURNAL (2013)
Pharmacokinetics of Non-Intravenous Formulations of Fentanyl
Joern Loetsch et al.
CLINICAL PHARMACOKINETICS (2013)
Physiologically-based pharmacokinetic model for Fentanyl in support of the development of Provisional Advisory Levels
Harish Shankaran et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Transdermal fentanyl for cancer pain
Gina Hadley et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
A Phase I Pharmacokinetic and Bioavailability Study of a Sublingual Fentanyl Wafer in Healthy Volunteers
Chin Beng Stephen Lim et al.
ANESTHESIA AND ANALGESIA (2012)
Inhaled Fentanyl Aerosol in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
David B. MacLeod et al.
ANESTHESIA AND ANALGESIA (2012)
Physiologically Based Pharmacokinetic (PBPK) Modeling in Children
J. S. Barrett et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials
R. Leong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Chest Wall Rigidity in Two Infants After Low-Dose Fentanyl Administration
Elisabeth Dewhirst et al.
PEDIATRIC EMERGENCY CARE (2012)
Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice
Trevor N. Johnson et al.
PEDIATRIC ANESTHESIA (2011)
Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study
Lona L. Christrup et al.
CLINICAL THERAPEUTICS (2008)
General approach for the calculation of tissue to plasma partition coefficients
Walter Schmitt
TOXICOLOGY IN VITRO (2008)
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl
Teijo I. Saari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Mechanistic approaches to volume of distribution predictions: Understanding the processes
Trudy Rodgers et al.
PHARMACEUTICAL RESEARCH (2007)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Reduction and lumping of physiologically based pharmacokinetic models:: Prediction of the disposition of fentanyl and pethidine in humans by successively simplified models
S Björkman
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2003)
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
Share Paper
